Cargando…

GRAFT-VS.-HOST REACTION IN TISSUE CULTURE

The primary purpose of this study has been to validate the in vitro graft-vs.-host reaction as an experimental system. Time-dose studies have been presented for cells obtained from spleen, thymus, cortisone-treated thymus, inguinal lymph node, mesenteric lymph node, thoracic duct, and bone marrow ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Auerbach, Robert, Shalaby, M. R.
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 1973
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2139455/ https://www.ncbi.nlm.nih.gov/pubmed/4148647

Ejemplares similares

GRAFT-VS.-HOST REACTIONS IN RECIPROCAL HYBRID MICE : I. DISSOCIATION OF T-CELL ACTIVITIES IN THE MIXED LYMPHOCYTE REACTION AND TWO GRAFT-VS.-HOST ASSAYS
por: Morse, Herbert C., et al.
Publicado: (1974)

Serum-mediated inhibition of graft-vs.-host reaction
Publicado: (1975)

Follicular Graft Vs Host Reaction: A Rare Presentation
por: Vashisht, Deepak, et al.
Publicado: (2020)

Lymphocyte-induced angiogenesis: a quantitative and sensitive assay of the graft-vs.-host reaction
Publicado: (1975)

THE ALLOGENEIC EFFECT IN INBRED MICE : IV. REGULATORY INFLUENCES OF GRAFT-VS.-HOST REACTIONS ON HOST T LYMPHOCYTE FUNCTIONS
por: Osborne, David P., et al.
Publicado: (1973)

INDUCTION OF A PRIMARY ANTIHAPTEN RESPONSE IN VIVO BY A GRAFT-VS.-HOST REACTION
por: Hamilton, J. A., et al.
Publicado: (1973)

Graft-versus-host Reactions in the Rabbit
por: Porter, K. A.
Publicado: (1960)

Macrophage regulation of graft-vs-host disease
por: Hong, Ya-Qun, et al.
Publicado: (2020)

Can Graft vs. Leukemia Effect Be Uncoupled From Graft vs. Host Disease? An Examination of Proportions
por: Krieger, Elizabeth, et al.
Publicado: (2020)

Human multipotent adult progenitor cells effectively reduce graft‐vs‐host disease while preserving graft‐vs‐leukemia activity
por: Metheny, Leland, et al.
Publicado: (2021)

Early cellular events in a systemic graft-vs.-host reaction. I. The migration of responding and nonresponding donor lymphocytes
Publicado: (1975)

Cytokine Detection and Modulation in Acute Graft vs. Host Disease in Mice
por: Knulst, A. C., et al.
Publicado: (1994)

Selective viral immunosuppression of the graft-versus-host reaction
Publicado: (1977)

Achievement of Tolerance Induction to Prevent Acute Graft-vs.-Host Disease
por: Thangavelu, Govindarajan, et al.
Publicado: (2019)

Inflammatory Cytokine Networks in Gastrointestinal Tract Graft vs. Host Disease
por: Piper, Clint, et al.
Publicado: (2019)

Virotherapy as Potential Adjunct Therapy for Graft-Vs-Host Disease
por: Villa, Nancy Y., et al.
Publicado: (2018)

Graft-vs-Host Disease Colitis After Lung Transplant
por: Kanthasamy, Kavin, et al.
Publicado: (2019)

Biomarkers of graft-vs-host disease: Understanding and applications for the future
por: Nagasawa, Masayuki
Publicado: (2021)

MECHANISM OF GRAFT-VERSUS-HOST-INDUCED LYMPHADENOPATHY IN MICE : TRAPPING VS. PROLIFERATION
por: Emeson, Eugene E., et al.
Publicado: (1973)

Role of Ia antigens in graft vs. host reactions. II. Molecular and functional analysis of T cell alloreactivity by the characterization of host Ia antigens on alloactivated donor T cells
Publicado: (1982)

Association of lpr gene with graft-vs.-host disease-like syndrome
Publicado: (1985)

Long-standing pili torti in 2 patients with chronic graft-vs-host disease
por: Penzi, Lauren R., et al.
Publicado: (2017)

A delicate balance: CD73-generated adenosine limits the severity of graft vs. host disease but also constrains the allogeneic graft vs. tumor effect
por: Thompson, Linda F., et al.
Publicado: (2013)

ICU Complications of Hematopoietic Stem Cell Transplant, Including Graft vs Host Disease
por: Stephens, R. Scott
Publicado: (2019)

Dendritic Cell Regulation of Graft-Vs.-Host Disease: Immunostimulation and Tolerance
por: Yu, Hongshuang, et al.
Publicado: (2019)

The IL-12 Cytokine and Receptor Family in Graft-vs.-Host Disease
por: Bastian, David, et al.
Publicado: (2019)

CYTOTOXICITY IN GRAFT-VERSUS-HOST REACTION : I. ROLE OF DONOR AND HOST SPLEEN CELLS
por: Singh, Jagat N., et al.
Publicado: (1972)

Genetic and pharmaceutical targeting of HIF1α allows combo-immunotherapy to boost graft vs. leukemia without exacerbation graft vs. host disease
por: Bailey, Christopher, et al.
Publicado: (2023)

Anti-leukaemia activity as a bystander effect of graft-versus-host reactions.
por: Johnson, P. R., et al.
Publicado: (1976)

RAPID VIRAL INDUCTION OF MURINE LYMPHOMAS IN THE GRAFT-VERSUS-HOST REACTION
por: Cornelius, Eugene A.
Publicado: (1972)

Chronic graft-vs-host disease in 2016: a major challenge and an opportunity
por: Pulanić, Dražen, et al.
Publicado: (2016)

Imatinib and dasatinib as salvage therapy for sclerotic chronic graft-vs-host disease
por: Sánchez-Ortega, Isabel, et al.
Publicado: (2016)

Ruxolitinib in steroid refractory graft-vs.-host disease: a case report
por: Maffini, Enrico, et al.
Publicado: (2016)

The Role of Co-stimulatory/Co-inhibitory Signals in Graft-vs.-Host Disease
por: Kumar, Sandeep, et al.
Publicado: (2018)

An Essential Role of Innate Lymphoid Cells in the Pathophysiology of Graft-vs.-Host Disease
por: Shao, Liang, et al.
Publicado: (2019)

Advances in the Use of Regulatory T-Cells for the Prevention and Therapy of Graft-vs.-Host Disease
por: Ramlal, Reshma, et al.
Publicado: (2017)

Graves’ Disease, a Late Complication of Chronic Graft vs Host Disease
por: Kreit, Helen, et al.
Publicado: (2021)

FRI100 Lipoprotein X In Graft Vs. Host Disease Affecting Liver
por: Vedamurthy, Deepak, et al.
Publicado: (2023)

Influence of dietary protein restriction on immune competence. I. Effect on the capacity of cells from various lymphoid organs to induce graft-vs.-host reactions
Publicado: (1975)

Allosuppressor and allohelper T cells in acute and chronic graft-vs- host disease. I. Alloreactive suppressor cells rather than killer T cells appear to be the decisive effector cells in lethal graft-vs.-host disease
Publicado: (1982)

Cannot write session to /tmp/vufind_sessions/sess_29ivdv5qeg30q7s85r6va3ikng